Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lennart Holm

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Lakartidningen|June 30, 2026
[Access to health data for research]Rolf Gedeborg, Lennart Holm, Pär Stattin
Pharmacoepidemiology and Drug Safety|January 11, 2017
Influence of age, sex and seriousness on reporting of adverse drug reactions in SwedenLennart Holm, Elisabet Ekman, Kerstin Jorsäter Blomgren
Upsala Journal of Medical Sciences|March 10, 2017
Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspectiveNils Feltelius, Rolf Gedeborg, Lennart Holm, et al.
European Journal of Clinical Pharmacology|November 26, 2008
Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysisJonatan D Lindh, Lennart Holm, Marine L Andersson, et al.
Clinical Pharmacology and Therapeutics|December 3, 2005
Several-fold increase in risk of overanticoagulation by CYP2C9 mutationsJonatan D Lindh, Stefan Lundgren, Lennart Holm, et al.
Journal of Thrombosis and Thrombolysis|May 22, 2007
Incidence and predictors of severe bleeding during warfarin treatmentJonatan D Lindh, Lennart Holm, Marja-Liisa Dahl, et al.
Pharmacoepidemiology and Drug Safety|January 14, 2017
Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry studyRolf Gedeborg, Bodil Svennblad, Lennart Holm, et al.
Plos One|September 14, 2016
Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and ReportingDiana M Rydberg, Lennart Holm, Ida Engqvist, et al.
European Journal of Clinical Pharmacology|October 8, 2013
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatmentDiana M Rydberg, Lennart Holm, Stefan Mejyr, et al.
Upsala Journal of Medical Sciences|May 24, 2023
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccinesRolf Gedeborg, Lennart Holm, Nils Feltelius, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Lakartidningen|June 30, 2026
[Access to health data for research]Rolf Gedeborg, Lennart Holm, Pär Stattin
Pharmacoepidemiology and Drug Safety|January 11, 2017
Influence of age, sex and seriousness on reporting of adverse drug reactions in SwedenLennart Holm, Elisabet Ekman, Kerstin Jorsäter Blomgren
Upsala Journal of Medical Sciences|March 10, 2017
Utility of registries for post-marketing evaluation of medicines. A survey of Swedish health care quality registries from a regulatory perspectiveNils Feltelius, Rolf Gedeborg, Lennart Holm, et al.
European Journal of Clinical Pharmacology|November 26, 2008
Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysisJonatan D Lindh, Lennart Holm, Marine L Andersson, et al.
Clinical Pharmacology and Therapeutics|December 3, 2005
Several-fold increase in risk of overanticoagulation by CYP2C9 mutationsJonatan D Lindh, Stefan Lundgren, Lennart Holm, et al.
Journal of Thrombosis and Thrombolysis|May 22, 2007
Incidence and predictors of severe bleeding during warfarin treatmentJonatan D Lindh, Lennart Holm, Marja-Liisa Dahl, et al.
Pharmacoepidemiology and Drug Safety|January 14, 2017
Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: using laboratory data to increase validity of a population-based registry studyRolf Gedeborg, Bodil Svennblad, Lennart Holm, et al.
Plos One|September 14, 2016
Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward - Prevalence, Preventability and ReportingDiana M Rydberg, Lennart Holm, Ida Engqvist, et al.
European Journal of Clinical Pharmacology|October 8, 2013
Sex differences in spontaneous reports on adverse bleeding events of antithrombotic treatmentDiana M Rydberg, Lennart Holm, Stefan Mejyr, et al.
Upsala Journal of Medical Sciences|May 24, 2023
Validation of myocarditis diagnoses in the Swedish patient register for analyses of potential adverse reactions to COVID-19 vaccinesRolf Gedeborg, Lennart Holm, Nils Feltelius, et al.
Pageof 2